4/A
Changes in Ownership
Aurinia Pharmaceuticals Inc. Filed Acc 0001628280-22-018767
Director acquired 10,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jayne David R.W. Director | 2022-05-18 | Option exercise | +10,000 | $3.62 | $36,200 | 40,000 | D |
| Derivatives | |||||||
| Jayne David R.W. Director | 2022-05-18 | Option exercise · Stock Option (right to buy) | −10,000 | 0 | D | ||
Loading xslF345X03/wf-form4a_165753457810786.xml…